Clinical Trial Update: Pilot Study of High-Concentration Capsaicin Patches in the Treatment of Painful HIV-Associated Neuropathy [Phase 2]

View source ↗

Summary

Phase 2 pilot study evaluating high-concentration capsaicin patches for painful HIV-associated neuropathy; the trial status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Hiv-associated Neuropathy

Drugs mentioned

• Qutenza (capsaicin patch) (capsaicin patch)

Snippet

Sponsor: NeurogesX | Conditions: HIV Infections | Phase 2 | Status: UNKNOWN